Navigation Links
Micromet Announces Public Offering of Common Stock
Date:7/29/2009

collaboration and license agreement with Bayer Schering Pharma AG under which Bayer Schering Pharma was granted an exclusive option until January 2010 to license a specified BiTE antibody against an undisclosed solid tumor target. Other BiTE antibodies targeting MSCP, CD33, HER2, EGFR and other targets are in various stages of preclinical development.

Forward-Looking Statements

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking statements include statements regarding the efficacy, safety and intended utilization of our product candidates, the conduct, timing and results of future clinical trials, and expectations of the future expansion of our product pipeline and collaborations. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product candidates that appeared promising in early research, preclinical studies or clinical trials do not demonstrate safety and/or efficacy in subsequent clinical trials, the risk that encouraging results from early research, preclinical studies or clinical trials may not be confirmed upon further analysis of the detailed results of such research, preclinical study or clinical trial, the risk that additional information relating to the safety, efficacy or tolerability of our product candidates may be discovered upon further analysis of preclinical or clinical trial data, the risk that we or our collaborators will no
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet, Inc. to Host Conference Call and Webcast to Report Second Quarter 2009 Financial Results on August 6, 2009
2. Micromet Added to Russell 3000 Index
3. Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8, 2009
4. Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel
5. Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO
6. Micromet, Inc. to Host Conference Call and Webcast to Report First Quarter 2009 Financial Results on May 6, 2009
7. Micromet Presents Data at AACR Meeting Showing Elimination of Colorectal Cancer Stem Cells by BiTE Antibody MT110
8. Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009
9. Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics
10. Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research
11. Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... 2013 Oven Industries, Inc. has been ... and temperature sensors since 1964. Expertly designed, the ... control system applications. As one of the ... generic, control loop feedback system, which helps minimize errors. ... adjust a systematic process, using a control element, like ...
(Date:5/16/2013)... May 16, 2013 Cambridge Healthtech Institute ... August 19-23, 2013 at the Renaissance Waterfront Hotel in ... provide a close-up look at the current strategies and ... bottom-line quality. Leaders in the field will reveal ... produce biopharmaceuticals with greater specificity and efficiency. , “In ...
(Date:5/16/2013)... May 16, 2013  The registration deadline has been ... Officers (ABFO) 2013 National Conference, the premier conference for ... 28-31 at the Hilton San Diego Bayfront. ... year,s conference and want to make sure as many ... Brandi Roberts , Chief Financial Officer ...
(Date:5/16/2013)... 2013 On average, developing a new ... billion dollars. Despite this investment, less than 10% of ... is your clinical trial design optimally structured to balance ... , Dr. Frederic Sax, Global Head of the Center ... of data, information and technology in upfront clinical trial ...
Breaking Biology Technology:New PID Temperature Controllers Announced by Oven Industries Inc. 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2
... future, every manufactured product our clothes, money, appliances, ... floors, our cars will be embedded with intelligence, ... termed smart dust or an Internet of Things. The ... We already have surveillance systems, biometrics, personal communicators, machine ...
... Feb. 1 MannKind Corporation,(Nasdaq: MNKD ), focused ... announced today that it will present at,the Merrill Lynch ... 2008 at 1:40 PM ET at the Grand Hyatt ... a link to the live web cast of the,presentation ...
... CORONA, Calif., Feb. 1 Watson,Pharmaceuticals, Inc. (NYSE: ... today that Paul Bisaro, Watson,s president and chief,executive ... the Company,s,business at the 2008 Merrill Lynch Global ... 5, 2008 at 1:40 p.m. Eastern,Standard Time., ...
Cached Biology Technology:Supportive devices or unnecessary surveillance? 2
(Date:5/16/2013)... entirety of an individual,s DNA is examined to look ... health problems is a massively useful technology for diagnosing ... problems if used incorrectly, say new recommendations from the ... today (16 May 2013) in the European Journal ... genome and on exome* sequencing and analysis are now ...
(Date:5/16/2013)... 2013 The consultancy Frost & ... to Germany,s largest biometrics manufacturer, ... system. DERMALOG has been honored yesterday night ... in the category Global Biometrics and Border Control  Customer ...   Border Control System . One of the decisive ...
(Date:5/15/2013)... - Clam fossils from the middle Devonian era ... better paleontological picture of the capacity of ecosystems to ... to research published today (May 15) in the online ... species abundance the head counts of specimens ... research shows that factors such as predation and organism ...
Breaking Biology News(10 mins):European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4Clam fossils divulge secrets of ecologic stability 2
... of male fallow deer provide rivals and potential mates with ... study, published in the open access journal BMC Biology ... change year by year and reflect changes in status and ... Mary, University of London together with Elisabetta Vannoni, University of ...
... (H5N1) outbreaks in Europe during the winter of 2005-2006 ... to researchers from Princeton University and the Erasmus Medical ... in the open-access journal PLoS Pathogens, show ... wild waterbirds away from areas of frozen water. ...
... 8, 2010) Autism Speaks, the world,s largest autism ... 16 new research grants totaling $5,223,743 over the next ... research, which provides the innovative discoveries that form the ... which further develops these discoveries in animal models, to ...
Cached Biology News:Honest deer every year 2Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 2Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 3Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 4Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 5Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 6Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 7
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure grade propidium iodide is greater than or equal to 98% pure by HPLC....
MOUSE ANTI RAT RT1Bu Immunogen: Rat thymocyte membrane glycoproteins...
... cloning of BAC (100+kb), fosmid (40kb), and ... stability than any othe BAC vector. On ... yields and easy recombinant DNA purification. Available ... (pSMART VC) vectors for the highest insert ...
SHEEP ANTI HUMAN ESTRONE...
Biology Products: